During the past budget period, the Birmingham CFAR has played a major role in the development of new programmatic areas both in basic and clinical AIDS research at UAB. This was accomplished by fostering in- house AIDS research through a competitive Developmental Grant Program and by recruitment of high caliber AIDS scientists from other institutions. Through these efforts, a considerable number of new research programs was initiated, the great majority of which have gone on to become competitive at a national level. Developmental Grant Program: Developmental monies ($416,740) were used to competitively fund 11 New Investigators and 8 Pilot Projects. These were selected from a total of 69 applications submitted to the CFAR Developmental Grant Program. All applications were prepared according to NIH guidelines, reviewed by an internal review committee, and funded solely based on scientific merit. Of the 19 competitive applications, 16 were subsequently submitted to national funding agencies, and 8 received extramural funding with total Direct Costs exceeding $5.5 million (3 are still pending review). Of the 50 non-funded proposals, 25 were submitted to national funding agencies, and six of these received extramural funds exceeding $1.6 million. The Developmental grant program has thus been extremely successful in facilitating new as well as nationally competitive research efforts. Recruitment: Developmental monies ($102,163) were used to assist in the recruitment of Dr. Patricia Fultz (HIV/SIV vaccine development and animal models) from Emory University and Dr. Victoria Johnson recruitment of Dr. Phillip Smith (HIV infection of the mucosa) from NIH, and Dr. Edward Hood (sexually transmitted diseases) from Johns Hopkins University, and Drs. Laura Leviton and Ralph DiClemente (HIV the Center assisted in the recruitment of three junior faculty, Drs. Mark Mulligan, John Kappes and Pauline Jolly (minority investigator). Each of these individuals greatly enhanced the scope and capabilities of the existing research programs. To continue these developmental efforts, funds are requested for two New Investigator Awards at the level of $25,000 per year as will as two Pilot Project awards at a level of $20,000 per year. These applications will be solicited, reviewed and funded as in the past. In addition, $10,000 per year are requested to support New Evolving Research Opportunities. These monies will fund AIDS projects of high significance that require immediate attention and a speedy resolution (funding decisions will be made by the CFAR Executive Committee). Finally, recruitment monies in the amount of $30,000 (years 02 through 05) are requested to continue to attract outstanding outside investigators to the UAB AIDS effort.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027767-10
Application #
2778654
Study Section
Project Start
Project End
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Peng, Binghao J; Carlson, Jonathan M; Liu, Michael K P et al. (2018) Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection. J Virol 92:
Shi, Bi; Geng, Jianlin; Wang, Yin-Hu et al. (2018) Foxp1 Negatively Regulates T Follicular Helper Cell Differentiation and Germinal Center Responses by Controlling Cell Migration and CTLA-4. J Immunol 200:586-594
Moshiri, Niema; Mirarab, Siavash (2018) A Two-State Model of Tree Evolution and Its Applications to Alu Retrotransposition. Syst Biol 67:475-489
Crockett, Kaylee B; Rice, Whitney S; Turan, Bulent (2018) Associations Between Multiple Forms of Discrimination and Tobacco Use Among People Living With HIV: The Mediating Role of Avoidance Coping. J Acquir Immune Defic Syndr 78:9-15
Mai, Uyen; Mirarab, Siavash (2018) TreeShrink: fast and accurate detection of outlier long branches in collections of phylogenetic trees. BMC Genomics 19:272
Tomalka, Amanda G; Resto-Garay, Ivelisse; Campbell, Kerry S et al. (2018) In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells. Front Immunol 9:2552
Ram, Daniel R; Manickam, Cordelia; Hueber, Brady et al. (2018) Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques. PLoS Pathog 14:e1007104
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Rice, Whitney S; Logie, Carmen H; Napoles, Tessa M et al. (2018) Perceptions of intersectional stigma among diverse women living with HIV in the United States. Soc Sci Med 208:9-17
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72

Showing the most recent 10 out of 955 publications